Opioid receptor
From Proteopedia
(Difference between revisions)
Line 48: | Line 48: | ||
**[[4dkl]] – mOpR + opioid antagonist <br /> | **[[4dkl]] – mOpR + opioid antagonist <br /> | ||
**[[5c1m]] – mOpR + opioid angonist <br /> | **[[5c1m]] – mOpR + opioid angonist <br /> | ||
- | **[[6ddf]] – mOpR + guanine nucleotide-binding protein + transducin + DAMGO – Cryo EM <br /> | + | **[[6ddf]] – mOpR + guanine nucleotide-binding protein + transducin + DAMGO peptide – Cryo EM <br /> |
+ | **[[6dde]] – mOpR + guanine nucleotide-binding protein + nanobody + DAMGO peptide – Cryo EM <br /> | ||
}} | }} | ||
Revision as of 09:47, 1 December 2021
|
3D structures of opioid receptor
Updated on 01-December-2021
References
- ↑ Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y. Current research on opioid receptor function. Curr Drug Targets. 2012 Feb;13(2):230-46. PMID:22204322
- ↑ Donica CL, Awwad HO, Thakker DR, Standifer KM. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Mol Pharmacol. 2013 May;83(5):907-18. doi: 10.1124/mol.112.084632. Epub 2013 Feb , 8. PMID:23395957 doi:http://dx.doi.org/10.1124/mol.112.084632
- ↑ Zaveri NT. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications. Curr Top Med Chem. 2011;11(9):1151-6. PMID:21050175
- ↑ Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr Drug Targets. 2007 Jan;8(1):117-35. PMID:17266536
- ↑ Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC. Structure of the human kappa-opioid receptor in complex with JDTic. Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939. PMID:22437504 doi:10.1038/nature10939
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Karsten Theis, Joel L. Sussman